News and Trends 6 Aug 2025 Fusion proteins attract funds and biopharma partnerships …By binding to the IL-2 receptor, Lymphir not only delivers its toxin payload to directly kill tumor cells, but it also temporarily depletes immunosuppressive regulatory T-cells called Tregs to unlock… August 6, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 Jun 2023 Five biotech companies making a name for themselves in Vancouver …to treat different diseases, helping them move quickly, reduce cost, and tackle some of the most challenging problems in drug development. In fact, AbCellera actually helped to develop the first… June 30, 2023 - 6 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 23 Jan 2025 mRNA, RNAi, circRNA, ASOs: A comparative guide to RNA therapeutics …particles, mimicking the response of the cell after natural infection. However, it might throw in the towel after it announced plans last year to can trials if it doesn’t obtain… January 23, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 27 Apr 2021 EMA Approvals for Multiple Sclerosis Highlight Treatment Shortfalls …response in patients and slowed the progression of the condition in a phase IIb/III trial last year. “To date, there is no treatment capable of effectively targeting the cells that… April 27, 2021 - 6 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 9 Jan 2018 Adaptimmune Gets the Green Light for its New T-cell Cancer Therapy …in the development of T-cell therapies for the treatment of cancer. It has been testing another one of its SPEAR T-cells in two pilot studies to determine the safety of… January 9, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Best in Biotech 9 Jul 2024 The 7 biotech companies in Portugal you should know about in 2024 …target cancer cells but also to the cells of the blood vessels that nourish the tumor. In preclinical trials, the platform was shown to work on breast cancer cells independently… July 9, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 6 Dec 2019 Dutch Startup Gets €9M to Create First Lab-Grown Pork Prototype …at the University of Cambridge, allows the transformation of animal stem cells into muscle cells, which are important for the mouthfeel, and fat cells, which contribute to the taste. “The… December 6, 2019 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 28 Jul 2021 Microbiome Medicines Could Power Up CAR-T Cell Therapies …cells to shrink tumors in mice. The research team focused on CD8 T cells, a type of immune cells that attack and kill viruses and tumors. In the paper, the… July 28, 2021 - 5 minutesmins - By Mark Zipkin Share WhatsApp Twitter Linkedin Email
In Depth 18 Sep 2024 Two targets, one solution: The rise of bispecific antibodies …assets. The company aims to develop T cell engagers, which are bispecific antibodies that bind to T cells and a molecule on a target cell, coercing the T cells to… September 18, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 19 Feb 2019 From Saving Endangered Rhinos to Enabling Lab-Grown Meat …take biopsies from the animals to keep up the production of meat. “At the moment, the only downside is the cost. It’s very expensive to grow iPSCs,” said Sullivan. What’s… February 19, 2019 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 13 Oct 2022 Agreement to take advantage of stem cells from first teeth …designer cells, next-generation cell therapies that will further enhance therapeutic efficacy by combining various technologies and devices with SHED. New treatment methods Under the agreement, the SHED Master Cell Bank… October 13, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Nov 2024 Six bispecific antibody companies you should know about …found in gliomas – and the CD3 receptor on T cells. This means that not only is the treatment localized and effective, but it also harnesses the body’s own defense… November 19, 2024 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email